Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Implications of the mitochondrial interactome of mammalian thioredoxin 2 for normal cellular function and disease.

Chasapis CT, Makridakis M, Damdimopoulos AE, Zoidakis J, Lygirou V, Mavroidis M, Vlahou A, Miranda-Vizuete A, Spyrou G, Vlamis-Gardikas A.

Free Radic Biol Med. 2019 Jun;137:59-73. doi: 10.1016/j.freeradbiomed.2019.04.018. Epub 2019 Apr 21.

PMID:
31018154
2.

Design, synthesis and evaluation of an anthraquinone derivative conjugated to myelin basic protein immunodominant (MBP85-99) epitope: Towards selective immunosuppression.

Tapeinou A, Giannopoulou E, Simal C, Hansen BE, Kalofonos H, Apostolopoulos V, Vlamis-Gardikas A, Tselios T.

Eur J Med Chem. 2018 Jan 1;143:621-631. doi: 10.1016/j.ejmech.2017.11.063. Epub 2017 Nov 24.

PMID:
29216561
3.

Recovery and quantification of a myelin oligodendrocyte glycoprotein peptide from rat plasma after protein precipitation.

Kontos C, Androutsou ME, Vlamis-Gardikas A, Tselios T.

Anal Biochem. 2017 Dec 1;538:71-73. doi: 10.1016/j.ab.2017.09.016. Epub 2017 Sep 27.

PMID:
28958915
4.

Myelin Oligodendrocyte Glycoprotein and Multiple Sclerosis.

Androutsou ME, Tapeinou A, Vlamis-Gardikas A, Tselios T.

Med Chem. 2018 Feb 6;14(2):120-128. doi: 10.2174/1573406413666170906123204. Review.

PMID:
28875859
5.

Identification of the zinc, copper and cadmium metalloproteome of the protozoon Tetrahymena thermophila by systematic bioinformatics.

Chasapis CT, Andreini C, Georgiopolou AK, Stefanidou ME, Vlamis-Gardikas A.

Arch Microbiol. 2017 Oct;199(8):1141-1149. doi: 10.1007/s00203-017-1385-y. Epub 2017 May 6.

PMID:
28478602
6.

Cervical Cancer Cell Line Secretome Highlights the Roles of Transforming Growth Factor-Beta-Induced Protein ig-h3, Peroxiredoxin-2, and NRF2 on Cervical Carcinogenesis.

Kontostathi G, Zoidakis J, Makridakis M, Lygirou V, Mermelekas G, Papadopoulos T, Vougas K, Vlamis-Gardikas A, Drakakis P, Loutradis D, Vlahou A, Anagnou NP, Pappa KI.

Biomed Res Int. 2017;2017:4180703. doi: 10.1155/2017/4180703. Epub 2017 Feb 2.

7.

Conjugation of a peptide to mannan and its confirmation by tricine sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Tapeinou A, Androutsou ME, Kyrtata K, Vlamis-Gardikas A, Apostolopoulos V, Matsoukas J, Tselios T.

Anal Biochem. 2015 Sep 15;485:43-5. doi: 10.1016/j.ab.2015.06.010. Epub 2015 Jun 14.

PMID:
26079707
8.

Expression of thioredoxins and glutaredoxins in human hepatocellular carcinoma: correlation to cell proliferation, tumor size and metabolic syndrome.

Mollbrink A, Jawad R, Vlamis-Gardikas A, Edenvik P, Isaksson B, Danielsson O, Stål P, Fernandes AP.

Int J Immunopathol Pharmacol. 2014 Apr-Jun;27(2):169-83.

PMID:
25004829
9.

Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione.

Lu J, Vlamis-Gardikas A, Kandasamy K, Zhao R, Gustafsson TN, Engstrand L, Hoffner S, Engman L, Holmgren A.

FASEB J. 2013 Apr;27(4):1394-403. doi: 10.1096/fj.12-223305. Epub 2012 Dec 17.

PMID:
23248236
10.

The -Cys-X1-X2-Cys- motif of reduced glutaredoxins adopts a consensus structure that explains the low pK(a) of its catalytic cysteine.

Foloppe N, Vlamis-Gardikas A, Nilsson L.

Biochemistry. 2012 Oct 16;51(41):8189-207. doi: 10.1021/bi3006576. Epub 2012 Oct 3.

PMID:
22966829
11.

Solution structure and biophysical properties of MqsA, a Zn-containing antitoxin from Escherichia coli.

Papadopoulos E, Collet JF, Vukojević V, Billeter M, Holmgren A, Gräslund A, Vlamis-Gardikas A.

Biochim Biophys Acta. 2012 Dec;1824(12):1401-8. doi: 10.1016/j.bbapap.2012.06.016. Epub 2012 Jul 10.

PMID:
22789559
12.

Purification and biophysical characterization of the core protease domain of anthrax lethal factor.

Gkazonis PV, Dalkas GA, Chasapis CT, Vlamis-Gardikas A, Bentrop D, Spyroulias GA.

Biochem Biophys Res Commun. 2010 Jun 4;396(3):643-7. doi: 10.1016/j.bbrc.2010.04.144. Epub 2010 May 8.

PMID:
20438702
13.

Insights into the anthrax lethal factor-substrate interaction and selectivity using docking and molecular dynamics simulations.

Dalkas GA, Papakyriakou A, Vlamis-Gardikas A, Spyroulias GA.

Protein Sci. 2009 Aug;18(8):1774-85. doi: 10.1002/pro.169.

14.

The multiple functions of the thiol-based electron flow pathways of Escherichia coli: Eternal concepts revisited.

Vlamis-Gardikas A.

Biochim Biophys Acta. 2008 Nov;1780(11):1170-200. doi: 10.1016/j.bbagen.2008.03.013. Epub 2008 Apr 1. Review.

PMID:
18423382
15.

Dendrin expression in glomerulogenesis and in human minimal change nephrotic syndrome.

Dunér F, Patrakka J, Xiao Z, Larsson J, Vlamis-Gardikas A, Pettersson E, Tryggvason K, Hultenby K, Wernerson A.

Nephrol Dial Transplant. 2008 Aug;23(8):2504-11. doi: 10.1093/ndt/gfn100. Epub 2008 Mar 20.

PMID:
18356187
16.

Low molecular weight inhibitors of the protease anthrax lethal factor.

Dalkas GA, Papakyriakou A, Vlamis-Gardikas A, Spyroulias GA.

Mini Rev Med Chem. 2008 Mar;8(3):290-306. Review.

PMID:
18336349
17.

Assignment of (1)H, (13)C, and (15)N resonances of YgiT, a putative DNA interacting protein from E. coli, containing one HTH and two CxxC motifs.

Papadopoulos E, Billeter M, Gräslund A, Vlamis-Gardikas A.

Biomol NMR Assign. 2007 Dec;1(2):217-9. doi: 10.1007/s12104-007-9060-x. Epub 2007 Nov 2.

PMID:
19636869
18.

Characterization of the native CREB3L2 transcription factor and the FUS/CREB3L2 chimera.

Panagopoulos I, Möller E, Dahlén A, Isaksson M, Mandahl N, Vlamis-Gardikas A, Mertens F.

Genes Chromosomes Cancer. 2007 Feb;46(2):181-91.

PMID:
17117415
19.

Molecular mapping of functionalities in the solution structure of reduced Grx4, a monothiol glutaredoxin from Escherichia coli.

Fladvad M, Bellanda M, Fernandes AP, Mammi S, Vlamis-Gardikas A, Holmgren A, Sunnerhagen M.

J Biol Chem. 2005 Jul 1;280(26):24553-61. Epub 2005 Apr 18.

20.

A novel monothiol glutaredoxin (Grx4) from Escherichia coli can serve as a substrate for thioredoxin reductase.

Fernandes AP, Fladvad M, Berndt C, Andrésen C, Lillig CH, Neubauer P, Sunnerhagen M, Holmgren A, Vlamis-Gardikas A.

J Biol Chem. 2005 Jul 1;280(26):24544-52. Epub 2005 Apr 15.

21.

Assessment of production conditions for efficient use of Escherichia coli in high-yield heterologous recombinant selenoprotein synthesis.

Rengby O, Johansson L, Carlson LA, Serini E, Vlamis-Gardikas A, Kårsnäs P, Arnér ES.

Appl Environ Microbiol. 2004 Sep;70(9):5159-67.

22.

Stimulation of Fe-S cluster insertion into apoFNR by Escherichia coli glutaredoxins 1, 2 and 3 in vitro.

Achebach S, Tran QH, Vlamis-Gardikas A, Müllner M, Holmgren A, Unden G.

FEBS Lett. 2004 May 7;565(1-3):203-6.

23.

Redox regulation of 3'-phosphoadenylylsulfate reductase from Escherichia coli by glutathione and glutaredoxins.

Lillig CH, Potamitou A, Schwenn JD, Vlamis-Gardikas A, Holmgren A.

J Biol Chem. 2003 Jun 20;278(25):22325-30. Epub 2003 Apr 7.

24.

Real-time kinetics of the interaction between the two subunits, Escherichia coli thioredoxin and gene 5 protein of phage T7 DNA polymerase.

Singha NC, Vlamis-Gardikas A, Holmgren A.

J Biol Chem. 2003 Jun 13;278(24):21421-8. Epub 2003 Mar 31.

25.

Characterization of the redox properties of poplar glutaredoxin.

Rouhier N, Vlamis-Gardikas A, Lillig CH, Berndt C, Schwenn JD, Holmgren A, Jacquot JP.

Antioxid Redox Signal. 2003 Feb;5(1):15-22.

PMID:
12626113
26.

Thioredoxin and glutaredoxin isoforms.

Vlamis-Gardikas A, Holmgren A.

Methods Enzymol. 2002;347:286-96. No abstract available.

PMID:
11898418
27.

Protein levels of Escherichia coli thioredoxins and glutaredoxins and their relation to null mutants, growth phase, and function.

Potamitou A, Holmgren A, Vlamis-Gardikas A.

J Biol Chem. 2002 May 24;277(21):18561-7. Epub 2002 Mar 13.

28.

Expression of Escherichia coli glutaredoxin 2 is mainly regulated by ppGpp and sigmaS.

Potamitou A, Neubauer P, Holmgren A, Vlamis-Gardikas A.

J Biol Chem. 2002 May 17;277(20):17775-80. Epub 2002 Mar 11.

29.

Characterization of Escherichia coli null mutants for glutaredoxin 2.

Vlamis-Gardikas A, Potamitou A, Zarivach R, Hochman A, Holmgren A.

J Biol Chem. 2002 Mar 29;277(13):10861-8. Epub 2001 Dec 10.

30.

Solution structure of Escherichia coli glutaredoxin-2 shows similarity to mammalian glutathione-S-transferases.

Xia B, Vlamis-Gardikas A, Holmgren A, Wright PE, Dyson HJ.

J Mol Biol. 2001 Jul 20;310(4):907-18.

PMID:
11453697
31.

Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways.

Daily D, Vlamis-Gardikas A, Offen D, Mittelman L, Melamed E, Holmgren A, Barzilai A.

J Biol Chem. 2001 Jun 15;276(24):21618-26. Epub 2001 Apr 4.

32.

Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by activating NF-kappa B via Ref-1.

Daily D, Vlamis-Gardikas A, Offen D, Mittelman L, Melamed E, Holmgren A, Barzilai A.

J Biol Chem. 2001 Jan 12;276(2):1335-44.

33.
34.

Assignment of 1H, 13C, and 15N resonances of reduced Escherichia coli glutaredoxin 2.

Xia B, Chung J, Vlamis-Gardikas A, Holmgren A, Wright PE, Dyson HJ.

J Biomol NMR. 1999 Jun;14(2):197-8. No abstract available.

PMID:
10427750
35.

New thioredoxins and glutaredoxins as electron donors of 3'-phosphoadenylylsulfate reductase.

Lillig CH, Prior A, Schwenn JD, Aslund F, Ritz D, Vlamis-Gardikas A, Holmgren A.

J Biol Chem. 1999 Mar 19;274(12):7695-8.

36.
37.

Naturally occurring mutants of human steroid 21-hydroxylase (P450c21) pinpoint residues important for enzyme activity and stability.

Nikoshkov A, Lajic S, Vlamis-Gardikas A, Tranebjaerg L, Holst M, Wedell A, Luthman H.

J Biol Chem. 1998 Mar 13;273(11):6163-5.

38.

Cloning, overexpression, and characterization of glutaredoxin 2, an atypical glutaredoxin from Escherichia coli.

Vlamis-Gardikas A, Aslund F, Spyrou G, Bergman T, Holmgren A.

J Biol Chem. 1997 Apr 25;272(17):11236-43.

39.

Expression of active horseradish peroxidase in Saccharomyces cerevisiae.

Vlamis-Gardikas A, Smith AT, Clements JM, Burke JF.

Biochem Soc Trans. 1992 May;20(2):111S. No abstract available.

PMID:
1397519

Supplemental Content

Loading ...
Support Center